Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
5don MSN
Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
UC Davis researchers engineered wheat that encourages soil bacteria to convert atmospheric nitrogen into plant-usable ...
5don MSN
Lyme disease often goes undetected when it's most treatable. These teens are working to change that.
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
America's next wave of scientific talent may come from Lambert High School, where students used CRISPR to develop a promising ...
The world's first treatment that uses CRISPR gene-editing technology has been approved. Exa-cel, also known by its brand name Casgevy, received its first regulatory approval on Nov. 16, 2023 from the ...
CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback